Physician profile
John Allen
NPI 1861665697
$2,011.02
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $140 · 2021: $96.75 · 2022: $3.88 · 2023: $4.70 · 2024: $43.99 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,223.50 | 2019 | |
| Saluda Medical Americas, INC. | $172.24 | 2025 | Evoke |
| Medtronic USA, INC. | $140.29 | 2020 | |
| Spr Therapeutics, INC | $117.39 | 2019-2024 | Sprint Pns System |
| Medtronic, INC. | $73.60 | 2021 | |
| Electronic Waveform Lab, INC. | $62.93 | 2019-2023 | |
| Mdd US Operations, LLC | $51.60 | 2019 | |
| Nevro Corp. | $26.37 | 2019 | |
| Bioventus LLC | $26.36 | 2019 | |
| Calliditas Therapeutics US INC. | $23.49 | 2024 | |
| Scilex Pharmaceuticals INC. | $19.60 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.12 | 2019 | |
| Daiichi Sankyo INC. | $16.45 | 2019 | |
| Kaleo, INC. | $14.66 | 2019 | |
| Biodelivery Sciences International, INC. | $14.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.